InvestorsHub Logo
Followers 21
Posts 154
Boards Moderated 0
Alias Born 05/27/2008

Re: Rdunn88 post# 198818

Monday, 10/02/2017 3:39:08 PM

Monday, October 02, 2017 3:39:08 PM

Post# of 403217
We don’t know that no partner reached out, we can only assume no deal has been finalized yet. With management being the largest shareholder - I assume they are evaluating all deals as they come. With waiting for additional positive trial results - we can keep negotiating a better deal. At some point, management will decide the benefit of a deal with increased funding can advance the company further along than what they can do by themselves. If we had no trial progression, I would be impatient for a deal. On the contrary, positive progress -considering the fact we are a small biotech has been truly remarkable. This will allow us the opportunity for life changing returns on our investment. These are complicated decisions and it is really naive for anyone to be passing judgment or an opinion - because we don’t have all the facts. No one is forcing anyone to invest here, it’s relatively high risk, but mitigated by the fact we have several trials and drugs and access to Aspire financing. My choice is to be patient and trust management. The likely reason for the persistent pessimism for those constantly in disagreement regardless of the announcement or clinical trial progress, is likely those who have a benefit for the share price to decline - short traders. Good luck to the Longs!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News